CD274 and neoplasm: FKBP51s may affect T cell activation and function by affecting PD-L1 folding and maturation, as well as promote Treg transcription and immunosuppressive ability by interacting with the Foxp3 transcription factor, which may influence tumor immune response and immunotherapy efficacy [164, 165].